Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company
Chase Therapeutics has raised $20.0M in total funding. The most recent round was Series B. The last funding was announced in October 2021.
Chase Therapeutics's investors include Revolution, Revolution’s Rise of the Rest Seed Fund, Brain Trust Accelerator Fund, China Link Capital.
Chase Therapeutics is headquartered in Washington, United States.
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company
Chase Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chase Therapeutics — Funding & Investors." VCBacked, October 20, 2021, https://www.vcbacked.co/company/chase-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Chase Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/chase-therapeutics
{{cite web |title=Chase Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/chase-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated